Orbimed Advisors LLC Kala Pharmaceuticals, Inc. Transaction History

Orbimed Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.74 $3.99 Million - $9.42 Million	-3,438,998 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.62 - $5.43 $5.31 Million - $11 Million	-2,026,032 Reduced 37.07%	3,438,998 $9.01 Million
Q3 2020 Nov 16, 2020	BUY	$7.5 - $11.11 $467,250 - $692,153	62,300 Added 1.15%	5,465,030 $41 Million
Q1 2020 May 15, 2020	BUY	$3.83 - $8.79 $7.49 Million - $17.2 Million	1,954,890 Added 56.7%	5,402,730 $47.5 Million
Q1 2018 May 15, 2018	BUY	$12.26 - $18.98 $13.1 Million - $20.4 Million	1,072,561 Added 45.16%	3,447,840 $54.6 Million
Q3 2017 Nov 14, 2017	BUY	$19.86 - $26.53 $47.2 Million - $63 Million	2,375,279	2,375,279 $54.3 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $7.69M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.